The DCGI had earlier granted permission to Biological E Limited to conduct phase 2/3 clinical trials on children aged between 5 and 18 years.

The DCGI had earlier granted permission to Biological E Limited to conduct phase 2/3 clinical trials on children aged between 5 and 18 years.